Clinical Trial Update: Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the safety and efficacy of everolimus for BK virus infection in kidney transplant recipients; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Virus Infection

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: University of California, San Francisco | Conditions: BK Virus Infection | Phase 4 | Status: COMPLETED | Results posted: 2016-08-15